Individual treatment effects of sodium‐glucose co‐transporter‐2 inhibitors on the risk of chronic kidney disease in patients with type 2 diabetes: A counterfactual prediction model based on real‐world data

Documenti analoghi

• Cost‐Utility Analysis of Different Treatment Modalities in Patients Undergoing Percutaneous Coronary Intervention: Thai PCI Registry
  di: Oraluck Pattanaprateep, et al.
  Pubblicazione: (2025)
• Comparative efficacy of pharmacotherapy and non‐pharmacotherapy for treating Alzheimer's disease: A systematic review and network meta‐analysis for cognitive, behavior and functional outcomes
  di: Chitima Boongird, et al.
  Pubblicazione: (2025)
• Retrospective Analysis of the Thai Percutaneous Coronary Intervention Registry: Impacts of Center Volume and Operator Experience on Outcomes
  di: Mann Chandavimol, et al.
  Pubblicazione: (2024)
• Characterization of treatment intensified (add‐on to metformin) adults with type 2 diabetes in Thailand: A cross‐sectional real‐world study (CONVERGE)
  di: Chutintorn Sriphrapradang, et al.
  Pubblicazione: (2025)
• Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus
  di: SophieAnne Buckley, et al.
  Pubblicazione: (2024)